Cartesian Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
S-1/A: Cartesian Therapeutics Files for Resale of 6.5 Million Shares Following Merger and Private Placement
Cartesian Therapeutics is registering for the resale of up to 6.5 million shares of its common stock by selling stockholders after a recent merger and private placement.
NASDAQ
Cartesian Therapeutics files an amendment to its S-1 registration statement to allow selling stockholders to resell up to 6.5 million shares of common stock.
NASDAQ
Cartesian Therapeutics has filed a registration statement for the resale of up to 6.5 million shares of its common stock by selling stockholders.